Benzinga··BenzingaNBTX Denies Acquisition Speculation, Refutes Media Claims
Nanobiotix denies acquisition speculation, stating no acquisition intent or assessment underway. Company cites factual inaccuracies in media reports.
NBTXbiotechnologyoncology